|
G. Steven Geis, PhD, MD, has served as a director of Kendle since November 2002. Now retired, Dr. Geis served in a number of senior R&D positions with Pharmacia & Upjohn Company from 1985 to July 2002, most recently as Group Vice President: Arthritis, Cardiovascular and Oncology Clinical Development. He currently operates his own consulting firm assisting biopharmaceutical companies with their drug development programs. Dr. Geis has authored or co-authored numerous journal articles covering several therapeutic areas. | 